Inogen manufactures and provides homecare oxygen therapy equipment and related services. The company is based in Goleta, California, and was accredited as a national homecare provider for oxygen therapy in 2009 under CEO Raymond Huggenberger. In April 2012 Inogen secured $20M in equity financing led by Novo A/S. The company said it will use the funds to expand sales and patient support resources and to spread awareness among oxygen therapy users. Inogen also plans to invest the proceeds in R&D and the commercialization of innovative new products to solidify its market position. No operating metrics were reported in the article. Inogen develops and manufactures portable oxygen therapy and respiratory home healthcare equipment intended to improve patients' freedom and independence. The company also operates as an Accredited Homecare Provider, enabling it to tailor products and deliver services directly in patients' homes. Inogen emphasizes cost‑effective solutions that increase efficiency for homecare providers while improving quality of life for users. The company promotes its products and services via its corporate and product websites. Management cites growth as a driver for seeking additional financing and partnership support. No operating metrics or prior financing details are provided in the article.

Total raised

$26M

Funding rounds

2

Latest round

Equity

Latest activity

Apr 2012